01.21.11
Symmetry Medical Inc. has undergone some leadership reshuffling.
The company’s board recently tapped Johnson & Johnson (J&J) vet Thomas J. Sullivan to serve as president and CEO, effective Jan. 17.
Brian S. Moore, Symmetry's previous president and CEO, will remain with the as president of Business Development. Moore also will continue as a member of the board of directors. He will remain with Symmetry through June 2012, with the option to stay on based on mutual agreement with the board.
Prior to Symmetry, Sullivan previously was president of the Supply Chain & Business Process division of Johnson & Johnson Health Care Systems, Inc., where he led the global supply chain competency center for the Medical Device & Diagnostics Group. He also led the Johnson & Johnson Supply Chain Customer Experience Team accountable for all customer facing logistics services across the Medical Device & Diagnostics, Pharmaceutical, and Consumer Groups worldwide. He held several senior leadership roles at J&J, beginning in 1990. Sullivan holds a Bachelor of Science in Applied Mathematics and Computer Science from the University of Pittsburgh and an MBA in Strategic Management and Information Technology from The Wharton School, University of Pennsylvania.
"We were most fortunate to attract Tom and found his industry and operational experience to be a perfect fit,” said Craig Reynolds, chairman of Symmetry’s board. “He has a strong mix of relevant leadership experience across a broad range of healthcare disciplines and is well versed in the largest segment of Symmetry's business, orthopedics."
Reynolds thanked Moore for his service as the company’s chief executive for the past seven and a half years. He said Moore would continue to “contribute to the business.” Moore oversaw Symmetry’s public stock offering, as well as a number of key acquisitions.
Based in Warsaw, Ind., Symmetry is a supplier to the orthopedic industry, providing implants and related instruments and cases. The company also designs, develops and produces these products for companies in other segments of the medical device market, including arthroscopy, dental, laparoscopy, osteobiologic and endoscopy sectors and provides limited specialized products and services to non-healthcare markets, such as aerospace.
The company’s board recently tapped Johnson & Johnson (J&J) vet Thomas J. Sullivan to serve as president and CEO, effective Jan. 17.
Prior to Symmetry, Sullivan previously was president of the Supply Chain & Business Process division of Johnson & Johnson Health Care Systems, Inc., where he led the global supply chain competency center for the Medical Device & Diagnostics Group. He also led the Johnson & Johnson Supply Chain Customer Experience Team accountable for all customer facing logistics services across the Medical Device & Diagnostics, Pharmaceutical, and Consumer Groups worldwide. He held several senior leadership roles at J&J, beginning in 1990. Sullivan holds a Bachelor of Science in Applied Mathematics and Computer Science from the University of Pittsburgh and an MBA in Strategic Management and Information Technology from The Wharton School, University of Pennsylvania.
"We were most fortunate to attract Tom and found his industry and operational experience to be a perfect fit,” said Craig Reynolds, chairman of Symmetry’s board. “He has a strong mix of relevant leadership experience across a broad range of healthcare disciplines and is well versed in the largest segment of Symmetry's business, orthopedics."
Reynolds thanked Moore for his service as the company’s chief executive for the past seven and a half years. He said Moore would continue to “contribute to the business.” Moore oversaw Symmetry’s public stock offering, as well as a number of key acquisitions.
Based in Warsaw, Ind., Symmetry is a supplier to the orthopedic industry, providing implants and related instruments and cases. The company also designs, develops and produces these products for companies in other segments of the medical device market, including arthroscopy, dental, laparoscopy, osteobiologic and endoscopy sectors and provides limited specialized products and services to non-healthcare markets, such as aerospace.